STOCKHOLDERS' EQUITY, Equity Incentive Plans (Details) - USD ($)		3 Months Ended
	Mar. 23, 2022	Mar. 31, 2022	Mar. 31, 2021
Restricted Stock Units [Abstract]
Restricted stock units vested over a period		4 years
Total stock-based compensation expense, Amount [Abstract]
Total stock-based compensation expense		$ 1,641,388	$ 781,397
Hayfin Credit Agreement [Member]
Fair Value Assumptions and Methodology [Abstract]
Expected term		7 years
Volatility	68.10%
Dividend yield	0.00%
Risk-free interest rate	2.36%
Research and Development [Member]
Total stock-based compensation expense, Amount [Abstract]
Total stock-based compensation expense		$ 4,671	105,227
Plasma Center Operating Expenses [Member]
Total stock-based compensation expense, Amount [Abstract]
Total stock-based compensation expense		21,052	10,818
Selling, General and Administrative [Member]
Total stock-based compensation expense, Amount [Abstract]
Total stock-based compensation expense		1,517,602	588,491
Cost of Product Revenue [Member]
Total stock-based compensation expense, Amount [Abstract]
Total stock-based compensation expense		98,063	$ 76,861
Equity Incentive Plans [Member]
Stock Options, Weighted Average Exercise Price [Abstract]
Unrecognized compensation expense, stock options		$ 3,800,000
Unrecognized compensation expense recognition period		2 years 7 months 6 days
Stock Options [Member]
Fair Value Assumptions and Methodology [Abstract]
Volatility		68.00%	69.00%
Dividend yield		0.00%	0.00%
Stock Options [Abstract]
Number of stock options granted (in shares)		1,194,032	1,441,050
Weighted average remaining contractual life of stock options, outstanding		6 years 7 months 6 days
Weighted average remaining contractual life of stock options, expected to vest		6 years 7 months 6 days
Weighted average remaining contractual life of stock options, exercisable		5 years 3 months 18 days
Stock Option, Shares [Abstract]
Options outstanding, vested and expected to vest, beginning balance (in shares)		7,862,722
Forfeited (in shares)		(9,186)
Expired (in shares)		(361,500)
Granted (in shares)		1,194,032
Options outstanding, vested and expected to vest, ending balance (in shares)		8,686,068
Options exercisable (in shares)		5,646,819
Stock Options, Weighted Average Exercise Price [Abstract]
Options outstanding, vested and expected to vest, weighted average exercise price, beginning balance (in dollars per share)		$ 3.93
Forfeited, weighted average exercise price (in dollars per share)		2.13
Expired, weighted average exercise price (in dollars per share)		6.48
Granted, weighted average exercise price (in dollars per share)		1.67
Options outstanding, vested and expected to vest, weighted average exercise price, ending balance (in dollars per share)		3.51
Options exercisable, weighted average exercise price (in dollars per share)		$ 4.25
Stock Options [Member] | Minimum [Member]
Fair Value Assumptions and Methodology [Abstract]
Expected term		5 years 6 months	5 years 6 months
Risk-free interest rate		1.72%	0.80%
Stock Options [Member] | Maximum [Member]
Fair Value Assumptions and Methodology [Abstract]
Expected term		6 years 3 months 18 days	6 years 3 months 18 days
Risk-free interest rate		1.73%	1.04%
Restricted Stock Units (RSUs) [Member]
Restricted Stock Units [Abstract]
Number of restricted stock units granted (in shares)		1,059,266	492,744
Shares withheld for tax withholding obligation (in shares)		265,929
Amount of shares withheld for tax withholding obligation		$ 400,000
Unvested RSU, Shares [Abstract]
Beginning balance (in shares)		4,485,133
Granted (in shares)		1,059,266
Vested (in shares)		(799,641)
Forfeited (in shares)		(15,000)
Ending balance (in shares)		4,729,758
Unvested RSU, Weighted Average Grant Date Fair Value
Unvested, Weighted average grant date fair value, beginning balance (in dollars per share)		$ 1.34
Granted, Weighted average grant date fair value (in dollars per share)		1.67
Vested, Weighted average grant date fair value (in dollars per share)		1.41
Forfeited, Weighted average grant date fair value (in dollars per share)		1.22
Unvested, Weighted average grant date fair value, ending balance (in dollars per share)		$ 1.41
Restricted Stock Units (RSUs) [Member] | Directors [Member]
Restricted Stock Units [Abstract]
Restricted stock units vested over a period		1 year
Restricted Stock Units (RSUs) [Member] | Employees [Member]
Restricted Stock Units [Abstract]
Restricted stock units vested over a period		4 years
Restricted Stock Units (RSUs) [Member] | Equity Incentive Plans [Member]
Stock Options, Weighted Average Exercise Price [Abstract]
Unrecognized compensation expense recognition period		2 years 8 months 12 days
Unvested RSU, Weighted Average Grant Date Fair Value
Unrecognized compensation expense, non option		$ 5,700,000
Milestone Based Restricted Stock (RSUs) [Member] | BIVIGAM [Member]
Unvested RSU, Shares [Abstract]
Vested (in shares)		(382,117)
Milestone Based Restricted Stock (RSUs) [Member] | Hayfin Credit Agreement [Member]
Unvested RSU, Shares [Abstract]
Vested (in shares)		(254,745)